Reproductive Endocrinology
From the Journals
Gonadotropins succeed where clomifene fails
Live births are significantly more likely among women who take gonadotropins, whether accompanied by intercourse or intrauterine insemination.
From the Journals
Iodine deficiency linked to delay in pregnancy
“The significant delay in time to pregnancy in that group raises serious concerns,” wrote James L. Mills, MD, of the NICHD.
From the Journals
Non-PCOS IVF: Two trials show no benefit with frozen embryo transfer
Frozen embryo transfer did not lead to higher live birth rates in two studies of women with non-PCOS infertility who were undergoing IVF.
From the Journals
Self-administered subcutaneous Depo-Provera ‘feasible and acceptable’
Self-injected contraception “has potential to reduce barriers and disparities in access,” wrote Dr. Julia E. Kohn.
From the Journals
Newer hormonal contraception formulations linked to breast cancer risk*
The elevated risk should be weighed against the benefits of contraception, researchers said.
Conference Coverage
Universal paternal Rh screening is cost effective in IVF
SAN ANTONIO – The strategy would save more than $1 million per 100,000 Rh negative pregnancies, if done in IVF populations.
Conference Coverage
Teach your adolescent patients about normal menses, so they know when it’s abnormal
CHICAGO – Use the menstrual cycle as a vital sign.
Conference Coverage
Young female hematologic cancer survivors have increased infertility risk
SAN ANTONIO – The study tracked infertility diagnoses among hematologic cancer survivors aged 16-34 years.
Conference Coverage
Are microRNAs the key to an endometriosis biomarker?
The miRNA combination test gives “an excellent diagnostic potential for endometriosis.”
Conference Coverage
Ulipristal acetate reduced bleeding for women with fibroids
SAN ANTONIO – About half of women in the VENUS II study achieved amenorrhea.
Commentary
Contraception coverage rollback is discriminatory
Policy shows the Trump administration’s lack of concern for women’s health.